Republicans are worried about their re-election prospects in 2020, and one result is a frenzy to “do something” on high drug prices. Yet two of the latest ideas are standbys of the left: foreign importation and pricing penalties, which are more about politics than results for patients.
The Trump Administration says it intends to explore ways “to allow safe importation of certain prescription drugs to lower prices and reduce out of pocket costs for American patients,” as Health and Human Services said in a press release.
